Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1275.05

3.30 (0.26%)

< Home < Back

Dr. Reddys Laboratories Ltd. News

>>

Dr. Reddy's Laboratories launches generic Semaglutide Injection in Canada

>>

Dr. Reddy’s Laboratories informs about press release

>>

Dr. Reddy's Laboratories reports 86% plunge in Q4FY26 consolidated net profit

>>

Dr. Reddy's Lab - Quaterly Results

>>

Dr. Reddy's Lab gets Health Canada’s nod for Generic Semaglutide Injection

>>

Dr. Reddy’s Laboratories informs about updates

>>

Dr. Reddy’s Laboratories informs about clarification on news item

>>

Dr. Reddy’s Laboratories informs about compliances certificate

>>

Dr. Reddy's Laboratories to sell entire shareholding in Svaas Wellness

>>

Dr. Reddy’s Laboratories launches Semaglutide injection ‘Obeda’ for Type 2 Diabetes

<< < 1 2 3 ...143 > >>